A carregar...
Targeted therapy in first line treatment of RAS wild type colorectal cancer
The debate on the optimal drug combination for treating chemotherapy-naïve patients with metastatic colorectal cancer has recently become particularly heated. The present editorial will review recent data on this topic. The FIRE-3 and PEAK trials have shown a 7.5 to 12 mo survival advantage with the...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356905/ https://ncbi.nlm.nih.gov/pubmed/25780283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i10.2871 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|